clinical trials
| 4 min read
7-methylxanthine is being reformulated into a sustained-release oral therapy aimed at improving long-term control of axial elongation in childhood myopia.
| 3 min read
Dehydrodolichyl diphosphate synthase (DHDSS)-related disease has no available treatments. The new work could finally change that with nicotinamide mononucleotide (NMN).
| 3 min read
As a new wave of chronic cough therapeutics enters clinical development, researchers are questioning whether the tools used to measure treatment effects are up to the task.
| 3 min read
The novel platform, called single-cell spatial pharmacobiology, revealed new insights into drug delivery of an antibody in Phase 1 trials.
| 4 min read
A first-in-human trial shows how computationally designed antigens could help shift vaccines from reactive to future-proof.
| 4 min read
As multiplexing platforms become more scalable and flexible, biomarkers are playing an increasingly central role in both preclinical and clinical decision-making.
| 5 min read
A first-in-class synaptic regenerative approach shows promise across multiple neurodegenerative and neuropsychiatric diseases.
| 4 min read
New regulatory frameworks, shifting incentives, and pragmatic trial designs could finally move patient engagement from rhetoric to reality.
| 3 min read
A policy update removes a longstanding barrier for medical device sponsors and signals a broader shift that could eventually reshape how drug and biologic developers approach evidence generation.
| 4 min read
Real-time clinical trials, pharma deals, cancer found to be rising in young people, and more led the news this week.
